Matisse Capital Trans Medics Group, Inc. Transaction History
Matisse Capital
- $205 Million
- Q3 2024
A detailed history of Matisse Capital transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Matisse Capital holds 5,000 shares of TMDX stock, worth $404,650. This represents 0.38% of its overall portfolio holdings.
Number of Shares
5,000
Previous 3,000
66.67%
Holding current value
$404,650
Previous $451,000
74.06%
% of portfolio
0.38%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding TMDX
# of Institutions
395Shares Held
31.9MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$291 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$214 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$117 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$103 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$88.5 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.58B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...